{"id":"plicamycin","rwe":[{"pmid":"41684293","year":"2026","title":"Identification of A p300-SP1-BRD4 Transcriptional Axis as a Key Driver of AR Hyperactivation in Polycystic Ovarian Syndrome.","finding":"","journal":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","studyType":"Clinical Study"},{"pmid":"41152825","year":"2025","title":"Single-cell landscape of mouse lungs exposed to intermittent hypoxia.","finding":"","journal":"Respiratory research","studyType":"Clinical Study"},{"pmid":"40346122","year":"2025","title":"SHP1 and its downstream p38/SP1/PI3K/YAP/Notch-1 signaling in trophoblast cells suppressed the progression of Preeclampsia via inhibiting proliferation of SMCs.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"},{"pmid":"40246177","year":"2025","title":"Inhibition of the Sp1/PI3K/AKT signaling pathway exacerbates doxorubicin-induced cardiomyopathy.","finding":"","journal":"Biochimica et biophysica acta. Molecular cell research","studyType":"Clinical Study"},{"pmid":"40202710","year":"2025","title":"Human umbilical cord mesenchymal stem cell exosomes promote elastin production and acute skin wound healing via TGFβ1-Smad pathway.","finding":"","journal":"Molecular and cellular biochemistry","studyType":"Clinical Study"}],"tags":[{"label":"plicamycin","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"L01DC02","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Malignant tumor of testis","category":"indication"},{"label":"Approved 1970s","category":"decade"},{"label":"Antibiotics, Antineoplastic","category":"pharmacology"},{"label":"Antineoplastic Agents","category":"pharmacology"},{"label":"Calcium-Regulating Hormones and Agents","category":"pharmacology"},{"label":"Coloring Agents","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Fluorescent Dyes","category":"pharmacology"},{"label":"Indicators and Reagents","category":"pharmacology"},{"label":"Luminescent Agents","category":"pharmacology"},{"label":"Nucleic Acid Synthesis Inhibitors","category":"pharmacology"},{"label":"Protein Synthesis Inhibitors","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=PLICAMYCIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:59:55.953781+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:00:03.326237+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=PLICAMYCIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:00:04.217236+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL509846/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:00:04.800587+00:00"}},"allNames":"mithramycin a","offLabel":[],"synonyms":["mithramycin","mithramycinum","plicamycin","aureolic acid","mithracin","Mithramycin A","mitramycin","plicatomycin"],"timeline":[{"date":"1970-05-05","type":"positive","source":"DrugCentral","milestone":"FDA approval"}],"approvals":[{"date":"1970-05-05","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Mithramycin A","ecosystem":[{"indication":"Malignant tumor of testis","otherDrugs":[{"name":"dactinomycin","slug":"dactinomycin","company":"Recordati Rare"},{"name":"etoposide","slug":"etoposide","company":""},{"name":"etoposide phosphate","slug":"etoposide-phosphate","company":"Bristol Myers Squibb"},{"name":"vinblastine","slug":"vinblastine","company":""}],"globalPrevalence":null}],"mechanism":{"novelty":"First-in-class","modality":"Small Molecule","drugClass":"plicamycin","explanation":"","oneSentence":"","technicalDetail":"Plicamycin binds to the minor groove of DNA, specifically to the guanine-cytosine base pair, and inhibits RNA polymerase, thereby preventing RNA synthesis and leading to cell death."},"commercial":{"launchDate":"1970","_launchSource":"DrugCentral (FDA 1970-05-05, )"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2223","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=PLICAMYCIN","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=PLICAMYCIN","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T15:21:54.895597","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:00:06.939022+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"bleomycin","drugSlug":"bleomycin","fdaApproval":"1973-07-31","genericCount":8,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"mitomycin","drugSlug":"mitomycin","fdaApproval":"1981-08-24","patentExpiry":"May 21, 2029","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"ixabepilone","drugSlug":"ixabepilone","fdaApproval":"2007-10-16","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"plicamycin","indications":{"approved":[{"name":"Malignant tumor of testis","source":"DrugCentral","snomedId":363449006,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"bleomycin","brandName":"bleomycin","genericName":"bleomycin","approvalYear":"1973","relationship":"same-class"},{"drugId":"mitomycin","brandName":"mitomycin","genericName":"mitomycin","approvalYear":"1981","relationship":"same-class"},{"drugId":"ixabepilone","brandName":"ixabepilone","genericName":"ixabepilone","approvalYear":"2007","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT02859415","phase":"PHASE1,PHASE2","title":"Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2019-08-08","conditions":["Esophageal Neoplasms","Lung Neoplasms","Mesothelioma","Thymus Neoplasms","Neoplasms, Germ Cell and Embryonal"],"enrollment":3,"completionDate":"2021-12-01"},{"nctId":"NCT01624090","phase":"PHASE2","title":"Mithramycin for Lung, Esophagus, and Other Chest Cancers","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2012-09-06","conditions":["Lung Cancer","Esophageal Cancer","Mesothelioma","Gastrointestinal Neoplasms","Breast Cancer"],"enrollment":16,"completionDate":"2019-09-27"},{"nctId":"NCT01610570","phase":"PHASE1,PHASE2","title":"Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2012-05-10","conditions":["Ewing Sarcoma","Sarcoma"],"enrollment":8,"completionDate":"2014-05-21"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000146714","MMSL":"1270","NDDF":"002658","UNII":"NIJ123W41V","VUID":"4018387","CHEBI":"CHEBI:31856","VANDF":"4018387","INN_ID":"2029","RXNORM":"204253","UMLSCUI":"C0026234","chemblId":"CHEMBL509846","ChEMBL_ID":"CHEMBL1237054","KEGG_DRUG":"D00468","DRUGBANK_ID":"DB06810","PDB_CHEM_ID":" QWP","PUBCHEM_CID":"163659","SNOMEDCT_US":"18335001","IUPHAR_LIGAND_ID":"8394","MESH_DESCRIPTOR_UI":"D008926","MESH_SUPPLEMENTAL_RECORD_UI":"C066851"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":75,"therapeuticAreas":["Oncology"],"atcClassification":{"source":"DrugCentral","atcCode":"L01DC02","allCodes":["L01DC02"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Feb 13","pmid":"41684293","title":"Identification of A p300-SP1-BRD4 Transcriptional Axis as a Key Driver of AR Hyperactivation in Polycystic Ovarian Syndrome.","journal":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)"},{"date":"2025 Oct 28","pmid":"41152825","title":"Single-cell landscape of mouse lungs exposed to intermittent hypoxia.","journal":"Respiratory research"},{"date":"2025 May 9","pmid":"40346122","title":"SHP1 and its downstream p38/SP1/PI3K/YAP/Notch-1 signaling in trophoblast cells suppressed the progression of Preeclampsia via inhibiting proliferation of SMCs.","journal":"Scientific reports"},{"date":"2025 Jun","pmid":"40246177","title":"Inhibition of the Sp1/PI3K/AKT signaling pathway exacerbates doxorubicin-induced cardiomyopathy.","journal":"Biochimica et biophysica acta. Molecular cell research"},{"date":"2025 Jul","pmid":"40202710","title":"Human umbilical cord mesenchymal stem cell exosomes promote elastin production and acute skin wound healing via TGFβ1-Smad pathway.","journal":"Molecular and cellular biochemistry"}],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"approved","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1970","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1970-05-05T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":"1970-05-05T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":"1970-05-05T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":"1970-05-05T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":"1970-05-05T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":"1970-05-05T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:00:06.939022+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}